SCHEMBL4933246

SCHEMBL4933246

CN1CCC(Oc2ccc(NC(=O)Nc3ccc(Oc4cc(Cl)ncn4)cc3)cc2C(F)(F)F)CC1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 18/20 0.63
FGFR1 P11362 2/20 0.63
BRAF P15056 9/20 0.59
RAF1 P04049 3/20 0.49
CDK2 P24941 2/20 0.49
CDK8 P49336 2/20 0.49
STK25 O00506 1/20 0.49
CIT O14578 1/20 0.49
MAP2K7 O14733 1/20 0.49
IKBKB O14920 1/20 0.49
AURKA O14965 1/20 0.49
GAK O14976 1/20 0.49
CHUK O15111 1/20 0.49
MUSK O15146 1/20 0.49
MAPK13 O15264 1/20 0.49
MAP3K13 O43283 1/20 0.49
DAPK3 O43293 1/20 0.49
MAP3K7 O43318 1/20 0.49
RIPK2 O43353 1/20 0.49
JAK2 O60674 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4932911 0.89 KDR (0.59) KDRFGFR1BRAFRAF1CDK2
SCHEMBL2776511 0.86 KDR (0.54) KDRFGFR1BRAFRAF1ARAF
SCHEMBL4937797 0.81 SRC (0.72) KDRFGFR1BRAFRAF1CDK2
SCHEMBL3177365 0.79 KDR (0.61) KDRBRAFRAF1CDK8MAPK14
SCHEMBL3167291 0.79 KDR (0.74) KDRFGFR1BRAFRAF1CDK2
SCHEMBL4932926 0.79 KDR (0.55) KDRBRAFRAF1RETMAPK14
SCHEMBL4279653 0.78 KDR (1.00) KDRFGFR1
Dimethylamine SCHEMBL4937315 0.78 RAF1 (0.61) KDRFGFR1BRAFRAF1CDK2
SCHEMBL4931395 0.77 KDR (0.60) KDRBRAFRAF1CDK8PDGFRB
SCHEMBL21465789 0.77 BRAF (0.57) KDRFGFR1BRAFRAF1ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080312192-A1 Diaryl Urea Derivatives in the Treatment of Protein Kinase Dependent Diseases BOLD GUIDO 2008-12-18 US claimed
US-20080312192-A1 Diaryl Urea Derivatives in the Treatment of Protein Kinase Dependent Diseases BOLD GUIDO 2008-12-18 US disclosed
US-20080312192-A1 Diaryl Urea Derivatives in the Treatment of Protein Kinase Dependent Diseases BOLD GUIDO 2008-12-18 US disclosed
US-20080312192-A1 Diaryl Urea Derivatives in the Treatment of Protein Kinase Dependent Diseases BOLD GUIDO 2008-12-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080312192-A1 Diaryl Urea Derivatives in the Treatment of Protein Kinase Dependent Diseases RET, PRKDC, PRKACA KDR 1309/4885FGFR1 1078/4885BRAF 65/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.